Oncotarget

Research Papers:

MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes

Maria M. Simile, Graziella Peitta, Maria L. Tomasi, Stefania Brozzetti, Claudio F. Feo, Alberto Porcu, Antonio Cigliano, Diego F. Calvisi, Francesco Feo and Rosa M. Pascale

PDF  |  HTML  |  Supplementary Files  |  Order a Reprint

Oncotarget. 2019; 10:2835-2854. https://doi.org/10.18632/oncotarget.26838

Metrics: PDF 271 views  |   HTML 337 views  |   ?  


Abstract

Maria M. Simile1, Graziella Peitta1, Maria L. Tomasi2, Stefania Brozzetti3, Claudio F. Feo4, Alberto Porcu4, Antonio Cigliano5, Diego F. Calvisi1, Francesco Feo1 and Rosa M. Pascale1

1 Department of Medical, Surgical and Experimental Sciences, Division of Experimental Pathology and Oncology, University of Sassari, Sassari, Italy

2 Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA

3 Department of Surgery “Pietro Valdoni”, University of Rome “La Sapienza”, Rome, Italy

4 Department of Medical, Surgical and Experimental Sciences, Division of Surgery, University of Sassari, Sassari, Italy

5 Institute of Pathology, University of Regensburg, Regensburg, Germany

Correspondence to:

Rosa M. Pascale,email: patsper@uniss.it

Keywords: methionine metabolism; methyladenosyltransferases; S-adenosylmethionine; HCC prognosis; HCC therapy

Received: November 08, 2018     Accepted: March 04, 2019     Published: April 19, 2019

ABSTRACT

Hepatocellular carcinoma (HCC) is characterized by the down-regulation of the liver-specific methyladenosyltransferase 1A (MAT1A) gene, encoding the S-adenosylmethionine synthesizing isozymes MATI/III, and the up-regulation of the widely expressed methyladenosyltransferase 2A (MAT2A), encoding MATII isozyme, and methyladenosyltransferase 2B (MAT2B), encoding a β-subunit without catalytic action that regulates MATII enzymatic activity. Different observations showed hepatocarcinogenesis inhibition by miR-203. We found that miR-203 expression in HCCs is inversely correlated with HCC proliferation and aggressiveness markers, and with MAT2A and MAT2B levels. MiR-203 transfection in HepG2 and Huh7 liver cancer cells targeted the 3’-UTR of MAT2A and MAT2B, inhibiting MAT2A and MAT2B mRNA levels and MATα2 and MATβ2 protein expression. These molecular events were paralleled by an increase in SAM content and were associated with growth restraint and apoptosis, inhibition of cell migration and invasiveness, and suppression of the expression of CD133 and LIN28B stemness markers. In contrast, MAT2B transfection in the same cell lines led to a rise of both MATβ2 and MATα2 expression, associated with increases in cell growth, migration, invasion and overexpression of stemness markers and p-AKT. Altogether, our results indicate that the miR-203 oncosuppressor activity may at least partially depend on its inhibition of MAT2A and MAT2B and show, for the first time, an oncogenic activity of MAT2B linked to AKT activation.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26838